Celldex Therapeutics, Inc. (CLDX)
USD 24.82
(-4.69%)
USD 24.82
(-4.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -107.29 Million | -103.73 Million | -60.9 Million | -40.4 Million | -46.41 Million | -75.23 Million |
| Net Income | -141.42 Million | -112.32 Million | -70.51 Million | -59.78 Million | -50.87 Million | -151.18 Million |
| Depreciation & Amortization | 3 Million | 2.89 Million | 3.06 Million | 3.92 Million | 4.85 Million | 3.8 Million |
| Deferred income taxes | -22.8 Million | -227 Thousand | -227 Thousand | -1.16 Million | 671 Thousand | -765 Thousand |
| Stock-based compensation | 23.89 Million | 15.61 Million | 8.95 Million | 3.91 Million | 4.55 Million | 8.08 Million |
| Change in working capital | 13.46 Million | -3.89 Million | -1.05 Million | -299 Thousand | -4.32 Million | -15.37 Million |
| Other non-cash items | 16.58 Million | -5.78 Million | -1.13 Million | 12.99 Million | -1.29 Million | 80.2 Million |
| Investing Cash Flow | -105.78 Million | 89.94 Million | -216.15 Million | -98.21 Million | 17.08 Million | 29.81 Million |
| Investments in PPE | -1.81 Million | -1.82 Million | -1.24 Million | -1.55 Million | -731 Thousand | -813 Thousand |
| Acquisitions | 103.96 Million | 69 Thousand | 27 Thousand | 55 Thousand | 20 Thousand | 342 Thousand |
| Investment purchases | -424.56 Million | -188.96 Million | -389.88 Million | -220.32 Million | -95.38 Million | -171.18 Million |
| Sales/Maturities of investments | 320.59 Million | 280.66 Million | 174.94 Million | 123.6 Million | 113.17 Million | 201.46 Million |
| Other Investing Activities | -103.96 Million | 69 Thousand | 27 Thousand | 55 Thousand | 20 Thousand | 342 Thousand |
| Financing Cash Flow | 218.45 Million | 4.07 Million | 272.37 Million | 171.22 Million | 16.25 Million | 29.44 Million |
| Debt repayment | - | - | - | -2.96 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 218.45 Million | 4.07 Million | 269.89 Million | 171.22 Million | 16.24 Million | 29.02 Million |
| Other Financing Activities | 218.45 Million | 4.07 Million | 2.47 Million | 171.22 Million | 9000.00 | 419 Thousand |
| Accounts receivables | -2.28 Million | -175 Thousand | 1.57 Million | -787 Thousand | -777 Thousand | -777 Thousand |
| Accounts payables | 9.38 Million | 3.12 Million | 3.65 Million | 1.63 Million | -13.11 Million | -13.11 Million |
| Inventory | - | - | - | - | 13.88 Million | 1.78 Million |
| Other working capital | 6.35 Million | -6.84 Million | -6.28 Million | -1.15 Million | -4.32 Million | -3.26 Million |
| Cash at beginning of period | 29.42 Million | 39.14 Million | 43.83 Million | 11.23 Million | 24.31 Million | 40.28 Million |
| Cash at end of period | 34.81 Million | 29.42 Million | 39.14 Million | 43.83 Million | 11.23 Million | 24.31 Million |
| Capital Expenditure | -1.81 Million | -1.82 Million | -1.24 Million | -1.55 Million | -731 Thousand | -813 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.38 Million | -9.71 Million | -4.69 Million | 32.6 Million | -13.07 Million | -15.97 Million |
| Free Cash Flow | -109.1 Million | -105.56 Million | -62.15 Million | -41.95 Million | -47.14 Million | -76.04 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.84 Million | -32.8 Million | -141.42 Million | -43.3 Million | -38.26 Million | -30.5 Million |
| Depreciation & Amortization | 797 Thousand | 775 Thousand | 3 Million | 759 Thousand | 767 Thousand | 756 Thousand |
| Deferred income taxes | - | - | -22.8 Million | 39.88 Million | -39.88 Million | - |
| Stock-based compensation | 7.64 Million | 7.2 Million | 23.89 Million | 7.21 Million | 7.12 Million | 5.21 Million |
| Change in working capital | 2.81 Million | -12.5 Million | 13.46 Million | 4.98 Million | 13 Million | -1.5 Million |
| Other non-cash items | 1.64 Million | 10.27 Million | 16.58 Million | -42.06 Million | 38.26 Million | -1.16 Million |
| Investing Cash Flow | -46.72 Million | -315.21 Million | -105.78 Million | -171.16 Million | 11.64 Million | 1.16 Million |
| Investments in PPE | -274 Thousand | -344 Thousand | -1.81 Million | -666 Thousand | -157 Thousand | -410 Thousand |
| Acquisitions | - | - | 103.96 Million | -585 Thousand | -11.8 Million | -1.57 Million |
| Investment purchases | -168.5 Million | -392.17 Million | -424.56 Million | -241.38 Million | -27.75 Million | -81.57 Million |
| Sales/Maturities of investments | 122.05 Million | 77.31 Million | 320.59 Million | 70.89 Million | 39.55 Million | 83.15 Million |
| Other Investing Activities | -46.44 Million | -344 Thousand | -103.96 Million | 585 Thousand | 11.8 Million | 1.57 Million |
| Financing Cash Flow | 3.71 Million | 436.11 Million | 218.45 Million | 217.37 Million | 257 Thousand | 133 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.71 Million | 436.11 Million | 218.45 Million | 217.37 Million | 257 Thousand | 133 Thousand |
| Other Financing Activities | 3.71 Million | 432.29 Million | 218.45 Million | -390 Thousand | 257 Thousand | 133 Thousand |
| Accounts receivables | 1.13 Million | -43 Thousand | -2.28 Million | -2.37 Million | -134 Thousand | 1.19 Million |
| Accounts payables | 1.71 Million | -4.78 Million | 9.38 Million | 3.87 Million | 8.47 Million | 478 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -33 Thousand | -7.67 Million | 6.35 Million | 3.48 Million | 4.66 Million | -3.18 Million |
| Cash at beginning of period | 115.07 Million | 34.81 Million | 29.42 Million | 21.13 Million | 28.22 Million | 54.12 Million |
| Cash at end of period | 42.73 Million | 115.07 Million | 34.81 Million | 34.81 Million | 21.13 Million | 28.22 Million |
| Capital Expenditure | -274 Thousand | -344 Thousand | -1.81 Million | -666 Thousand | -157 Thousand | -410 Thousand |
| Effect of forex changes on cash | - | - | - | 31.17 Million | -31.17 Million | - |
| Net cash flow / Change in cash | -72.33 Million | 80.26 Million | 5.38 Million | 13.68 Million | -7.09 Million | -25.89 Million |
| Free Cash Flow | -29.6 Million | -40.98 Million | -109.1 Million | -33.19 Million | -19.15 Million | -27.6 Million |
CTXXF
HATM
IGN
LGRVF
AAV
DMR